Johnson & Johnson RWE Expert Shares Thoughts on Transparency

In a recent interview, Jesse Berlin of Johnson & Johnson discusses how real world evidence (RWE) has shifted the research and development landscape. He notes that RWE is expected to provide greater transparency in clinical trials.

“In this interview, following his involvement in the publication of STaRT-RWE, a structured template tool for the planning and reporting on real-world evidence (RWE) study implementation, Jesse Berlin, Vice President and Global Head of Epidemiology for Johnson & Johnson (PA, USA), discusses challenges associated with working with real-world and epidemiologic data, as well as how we may help advance transparency in the context of studies utilizing these.” Read more here.

(Source: Jesse Berlin, The Evidence Base, 4/27/21)